SV

Srinivasan Venguduswami

Active Director Director DIN 08037011
DIN 08037011 First appointment Mar 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasan Venguduswami

Data last updated:

Srinivasan Venguduswami is a Director at Yaal Pharmaceuticals Private Limited (since 2018). The company operates in Business Services.

DIN 08037011
Primary Designation Director
Industry Business Services
First Appointment 07 Mar 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yaal Pharmaceuticals Private Limited U74999TN2018PTC121216
Director07 Mar 20182018Active

Board colleagues of Srinivasan Venguduswami

NameDINCompanyDesignation
Nithya Srinivasan08037010Yaal Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yaal Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srinivasan Venguduswami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasan Venguduswami

Srinivasan Venguduswami currently holds 1 directorship: Yaal Pharmaceuticals Private Limited (Director, since 07 Mar 2018).

Srinivasan Venguduswami was first appointed on 07 Mar 2018 as Director at Yaal Pharmaceuticals Private Limited.

The current boards of Srinivasan Venguduswami's companies include Nithya Srinivasan (Yaal Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available